|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 5 (March 1), 2000:
pp. 1541-1550
PLENARY PAPER
Leukemia initiated by PMLRAR : the PML domain plays a
critical role while retinoic acid-mediated transactivation is
dispensable
Scott C. Kogan,
Suk-hyun Hong,
David B. Shultz,
Martin L. Privalsky, and
J. Michael Bishop
From the G.W. Hooper Foundation and Departments of Laboratory
Medicine and Microbiology & Immunology, University of California, San
Francisco, CA; and the Section of Microbiology, Division of Biological
Sciences, University of California, Davis, CA.
The most common chromosomal translocation in acute promyelocytic
leukemia (APL), t15;17(q22;q21), creates PMLRAR and
RARPML fusion genes. We previously developed a mouse model
of APL by expressing PMLRAR in murine myeloid cells. In
order to examine the mechanisms by which PMLRAR can initiate
leukemia, we have now generated transgenic mice expressing
PMLRARm4 and RARm4, proteins that are unable to
activate transcription in response to retinoic acid.
PMLRARm4 transgenic mice developed myeloid leukemia,
demonstrating that transcriptional activation by PMLRAR is
not required for leukemic transformation. The characteristics of the
leukemias arising in the PMLRARm4 transgenic mice varied from those previously observed in our PMLRAR transgenic
mice, indicating that ligand responsiveness may influence the phenotype of the leukemic cells. The leukemias that arose in PMLRARm4
transgenic mice did not differentiate in response to retinoic acid
therapy. This result supports the hypothesis that a major therapeutic
effect of retinoic acid is mediated directly through the
PMLRAR protein. However, a variable effect on survival
suggested that this agent may be of some benefit in APL even when
leukemic cells are resistant to its differentiative effects.
Transgenic mice expressing high levels of RARm4 have
not developed leukemia, providing evidence that the PML domain of
PMLRAR plays a specific and critical role in the
pathogenesis of APL.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
F. Guidez, S. Parks, H. Wong, J. V. Jovanovic, A. Mays, A. F. Gilkes, K. I. Mills, M.-C. Guillemin, R. M. Hobbs, P. P. Pandolfi, et al.
RAR{alpha}-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia
PNAS,
November 20, 2007;
104(47):
18694 - 18699.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. L. Reineke, H. Liu, M. Lam, Y. Liu, and H.-Y. Kao
Aberrant Association of Promyelocytic Leukemia Protein-Retinoic Acid Receptor-{alpha} with Coactivators Contributes to Its Ability to Regulate Gene Expression
J. Biol. Chem.,
June 22, 2007;
282(25):
18584 - 18596.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Yang, J.-H. Jeong, A. L. Brown, C.-H. Lee, P. P. Pandolfi, J. H. Chung, and M. K. Kim
Promyelocytic Leukemia Activates Chk2 by Mediating Chk2 Autophosphorylation
J. Biol. Chem.,
September 8, 2006;
281(36):
26645 - 26654.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Kamashev, D. Vitoux, and H. de The
PML-RARA-RXR Oligomers Mediate Retinoid and Rexinoid/cAMP Cross-Talk in Acute Promyelocytic Leukemia Cell Differentiation
J. Exp. Med.,
April 19, 2004;
199(8):
1163 - 1174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gurrieri, K. Nafa, T. Merghoub, R. Bernardi, P. Capodieci, A. Biondi, S. Nimer, D. Douer, C. Cordon-Cardo, R. Gallagher, et al.
Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia
Blood,
March 15, 2004;
103(6):
2358 - 2362.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gurrieri, P. Capodieci, R. Bernardi, P. P. Scaglioni, K. Nafa, L. J. Rush, D. A. Verbel, C. Cordon-Cardo, and P. P. Pandolfi
Loss of the Tumor Suppressor PML in Human Cancers of Multiple Histologic Origins
J Natl Cancer Inst,
February 18, 2004;
96(4):
269 - 279.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. T. Phan, D. B. Shultz, B.-T. H. Truong, T. J. Blake, A. L. Brown, T. J. Gonda, M. M. Le Beau, and S. C. Kogan
Cooperation of Cytokine Signaling with Chimeric Transcription Factors in Leukemogenesis: PML-Retinoic Acid Receptor Alpha Blocks Growth Factor-Mediated Differentiation
Mol. Cell. Biol.,
July 1, 2003;
23(13):
4573 - 4585.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Farboud, H. Hauksdottir, Y. Wu, and M. L. Privalsky
Isotype-Restricted Corepressor Recruitment: a Constitutively Closed Helix 12 Conformation in Retinoic Acid Receptors {beta} and {gamma} Interferes with Corepressor Recruitment and Prevents Transcriptional Repression
Mol. Cell. Biol.,
April 15, 2003;
23(8):
2844 - 2858.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Sohal, V. T. Phan, P. V. Chan, E. M. Davis, B. Patel, L. M. Kelly, T. J. Abrams, A. M. O'Farrell, D. G. Gilliland, M. M. Le Beau, et al.
A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657
Blood,
April 15, 2003;
101(8):
3188 - 3197.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B.-T. H. Truong, Y.-J. Lee, T. A. Lodie, D. J. Park, D. Perrotti, N. Watanabe, H. P. Koeffler, H. Nakajima, D. G. Tenen, and S. C. Kogan
CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia
Blood,
February 1, 2003;
101(3):
1141 - 1148.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Li, P. Chen, N. Sinogeeva, M. Gorospe, R. P. Wersto, F. J. Chrest, J. Barnes, and Y. Liu
Arsenic Trioxide Promotes Histone H3 Phosphoacetylation at the Chromatin of CASPASE-10 in Acute Promyelocytic Leukemia Cells
J. Biol. Chem.,
December 13, 2002;
277(51):
49504 - 49510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-C. Guillemin, E. Raffoux, D. Vitoux, S. Kogan, H. Soilihi, V. Lallemand-Breitenbach, J. Zhu, A. Janin, M.-T. Daniel, B. Gourmel, et al.
In Vivo Activation of cAMP Signaling Induces Growth Arrest and Differentiation in Acute Promyelocytic Leukemia
J. Exp. Med.,
November 18, 2002;
196(10):
1373 - 1380.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Minucci, S. Monestiroli, S. Giavara, S. Ronzoni, F. Marchesi, A. Insinga, D. Diverio, P. Gasparini, M. Capillo, E. Colombo, et al.
PML-RAR induces promyelocytic leukemias with high efficiency following retroviral gene transfer into purified murine hematopoietic progenitors
Blood,
September 26, 2002;
100(8):
2989 - 2995.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Westervelt, J. L. Pollock, K. M. Oldfather, M. J. Walter, M. K. Ma, A. Williams, J. F. DiPersio, and T. J. Ley
Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia
PNAS,
July 9, 2002;
99(14):
9468 - 9473.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F.-M. Boisvert, M. J. Kruhlak, A. K. Box, M. J. Hendzel, and D. P. Bazett-Jones
The Transcription Coactivator CBP is a Dynamic Component of the Promyelocytic Leukemia Nuclear Body
J. Cell Biol.,
March 5, 2001;
152(5):
1099 - 1106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Kastner, H. J. Lawrence, C. Waltzinger, N. B. Ghyselinck, P. Chambon, and S. Chan
Positive and negative regulation of granulopoiesis by endogenous RAR{alpha}
Blood,
March 1, 2001;
97(5):
1314 - 1320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Kogan, D. E. Brown, D. B. Shultz, B.-T. H. Truong, V. Lallemand-Breitenbach, M.-C. Guillemin, E. Lagasse, I. L. Weissman, and J. M. Bishop
BCL-2 Cooperates with Promyelocytic Leukemia Retinoic Acid Receptor {{alpha}} Chimeric Protein (PMLRAR{{alpha}}) to Block Neutrophil Differentiation and Initiate Acute Leukemia
J. Exp. Med.,
February 20, 2001;
193(4):
531 - 544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Grimwade, A. Biondi, M.-J. Mozziconacci, A. Hagemeijer, R. Berger, M. Neat, K. Howe, N. Dastugue, J. Jansen, I. Radford-Weiss, et al.
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party
Blood,
August 15, 2000;
96(4):
1297 - 1308.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
